Experts Have Questions About FDA's New Priority Review Program

Experts Have Questions About FDA's New Priority Review Program

(MedPage Today) -- While there's little disagreement that speeding drug approvals would be a good thing, there are more questions than answers about the FDA's new national priority voucher program, experts told MedPage Today. Earlier this month...

Mid-Year Roundup: FDA’s Novel Retail and Specialty Drug Approvals in 2025

Explore the latest FDA-approved novel drugs transforming treatment options for various conditions, enhancing patient care and outcomes in community and specialty pharmacy.